Vitamin E therapy for NAFLD/NASH

My colleagues and I read with great interest the recent article by Ji and colleagues reporting the effect of vitamin E on serum aminotransferase levels in patients with nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), and chronic hepatitis C, evaluated by meta-analysis [1]. NAFLD is increasingly recognized as a common cause of chronic liver diseases in association with the current epidemic prevalence of obesity and diabetes mellitus in the general population. NAFLD is now regarded as a manifestation of metabolic syndrome and the link between obesity, diabetes mellitus, cardiovascular disease and NAFLD is likely to reflect shared pathogenic factors.
Source: Nutrition - Category: Nutrition Authors: Tags: Letter to the Editor Source Type: research